Minor Histocompatibility Antigens
"Minor Histocompatibility Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Allelic alloantigens often responsible for weak graft rejection in cases when (major) histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the H-Y antigen.
| Descriptor ID |
D015778
|
| MeSH Number(s) |
D23.050.301.500.600 D23.050.705.552.600
|
| Concept/Terms |
Minor Histocompatibility Antigens- Minor Histocompatibility Antigens
- Histocompatibility Antigens, Minor
- Minor Histocompatibility Peptides
- Histocompatibility Peptides, Minor
|
Below are MeSH descriptors whose meaning is more general than "Minor Histocompatibility Antigens".
Below are MeSH descriptors whose meaning is more specific than "Minor Histocompatibility Antigens".
This graph shows the total number of publications written about "Minor Histocompatibility Antigens" by people in this website by year, and whether "Minor Histocompatibility Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 2 | 3 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Minor Histocompatibility Antigens" by people in Profiles.
-
Histone demethylase KDM5D upregulation drives sex differences in colon cancer. Nature. 2023 Jul; 619(7970):632-639.
-
ZTTK syndrome: Clinical and molecular findings of?15 cases and a review of the literature. Am J Med Genet A. 2021 12; 185(12):3740-3753.
-
Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer. Clin Pharmacol Ther. 2021 10; 110(4):1038-1049.
-
An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformation. Prog Biophys Mol Biol. 2021 08; 163:143-159.
-
Alternative splicing of MR1 regulates antigen presentation to MAIT cells. Sci Rep. 2020 09 22; 10(1):15429.
-
Interleukin 27 Protects From Gastric Atrophy and Metaplasia During Chronic Autoimmune Gastritis. Cell Mol Gastroenterol Hepatol. 2020; 10(3):561-579.
-
TFEB controls retromer expression in response to nutrient availability. J Cell Biol. 2019 12 02; 218(12):3954-3966.
-
Formate concentrations in maternal plasma during pregnancy and in cord blood in a cohort of pregnant Canadian women: relations to genetic polymorphisms and plasma metabolites. Am J Clin Nutr. 2019 11 01; 110(5):1131-1137.
-
Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma. JCI Insight. 2019 10 03; 4(19).
-
Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells. Oncogene. 2020 01; 39(4):801-813.